Contrast-enhanced spectral mammography is a recently introduced mammographic method in which Forgia et al. have discussed imaging features of two cancer molecular subtypes, i.e., HER-2 positive and triple-negative, with the help of radiomics [26]. The gene discussed is ERBB2; the disease is cancer.